****** Gene Therapy Market is Expected to Thrive at a CAGR of 33.3% Forecast period 2017-2023

A Comprehensive research study conducted by KD Market Insights on “Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Applications (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases) – ****** Opportunity Analysis and Industry Forecast, 2017-2023” report offers extensive and highly detailed historical, current and future market trends in the ****** and regional/market. The Gene Therapy Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

The ****** Gene Therapy Market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. Gene therapy is a technique that involves the delivery of nucleic acid polymers into a patient’s cells as a drug to treat diseases. It fixes a genetic problem at its source. The process involves modifying the protein either to change the genetic expression or to correct a mutation. The emergence of this technology meets the rise in needs for better diagnostics and targeted therapy tools. For instance, genetic engineering can be used to modify physical appearance, metabolism, physical capabilities, and mental abilities such as memory and intelligence. In addition, it is also used for infertility treatment. Gene therapy offers a ray of hope for patients, who either have no treatment options or show no benefits with drugs currently available. The ongoing success has strongly supported upcoming researches and has carved ways for enhancement of gene therapy.

Request for Sample @ https://www.kdmarketinsights.com/sample/3544

The gene therapy market is a widely expanding field in the pharmaceutical industry with new opportunities. This has piqued the interests of venture capitalists to explore this market and its commercial potential. Major factors that drive the growth of this market include high demands for DNA vaccines to treat genetic diseases, targeted drug delivery, and high incidence of genetic disorders. However, the stringent regulatory approval process for gene therapy and the high costs of gene therapy drugs are expected to hinder the growth of the market.

The ****** gene therapy market is segmented based on vector type, gene type, application, and geography. Based on vector type, it is categorized into viral vector and non-viral vector. Viral vector is further segmented into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. Non-viral vector is further categorized into naked/plasmid vectors, gene gun, electroporation, lipofection, and others. Based on gene type, the market is classified into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. Based on application, the market is divided into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS
– This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
– The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
– In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
– The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS
By Vector Type
– Viral vector
– – Retroviruses
– – Lentiviruses
– – Adenoviruses
– – Adeno Associated Virus
– – Herpes Simplex Virus
– – Poxvirus
– – Vaccinia Virus
– – Others
– Non-viral vector
– – Naked/Plasmid Vectors
– – Gene Gun
– – Electroporation
– – Lipofection
– – Others

By Gene Type
– Antigen
– Cytokine
– Tumor Suppressor
– Suicide
– Deficiency
– Growth factors
– Receptors
– Others

By Application
– Oncological Disorders
– Rare Diseases
– Cardiovascular Diseases
– Neurological Disorders
– Infectious disease
– Other Diseases

By Region
– North America
– – U.S.
– – Canada
– – Mexico
– Europe
– – Germany
– – UK
– – France
– – Spain
– – Italy
– – Rest of Europe
– Asia-Pacific
– – Japan
– – China
– – India
– – South Korea
– – Rest of Asia-Pacific
– LAMEA
– – Brazil
– – Republic of South Africa
– – Rest of LAMEA

KEY PLAYERS PROFILED
– Novartis
– Kite Pharma, Inc.
– GlaxoSmithKline PLC
– Spark Therapeutics Inc.
– Bluebird bio Inc.
– Genethon
– Transgene SA
– Applied Genetic Technologies Corporation
– Oxford BioMedica
– NewLink Genetics Corp.

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/gene-therapy-market-amr
Table of Contents:
 
CHAPTER 1 INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
 
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Top winning strategies, by year, 2015-2017*
3.2.2.2. Top winning strategies, by development, 2015-2017* (%)
3.2.2.3. Top winning strategies, by company, 2015-2017*
3.3. Top player positioning, 2016
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High investment for R&D activities pertaining to gene therapy
3.5.1.2. Increase in prevalence of cancer
3.5.1.3. Growth in awareness regarding gene therapy
3.5.2. Restraints
3.5.2.1. High cost associated with gene therapies
3.5.2.2. Unwanted immune responses
3.5.3. Opportunity
3.5.3.1. Untapped potential for emerging markets

CHAPTER 4: GENE THERAPY MARKET, BY VECTOR TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Viral vectors
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market Analysis by country
4.2.5. Adenovirus
4.2.6. Lentivirus
4.2.7. Retrovirus
4.2.8. Adeno-associated virus
4.2.9. Herpes simplex virus
4.2.10. Poxvirus
4.2.11. Vaccinia virus
4.2.12. Others
4.3. Nonviral techniques
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Market Analysis by country
4.3.5. Naked plasmid vector
4.3.6. Gene gun
4.3.7. Electroporation
4.3.8. Lipofection
4.3.9. Others

CHAPTER 5: GENE THERAPY MARKET, BY GENE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Antigen
5.2.1. Market size and forecast
5.2.2. Market size and forecast by country
5.3. Cytokine
5.3.1. Market size and forecast
5.3.2. Market Analysis, by country
5.4. Tumor suppressor
5.4.1. Market size and forecast
5.4.2. Market Analysis, by country
5.5. Suicide
5.5.1. Market size and forecast
5.5.2. Market Analysis, by country
Continue…
 
Check for Discount @ https://www.kdmarketinsights.com/discount/3544 
 
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:
 
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com  

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.